Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERSIST ASTHMA-1: Felcorekibart in Uncontrolled Asthma
NCT07780643Phase 3Recruiting
- Sponsor
- GSK
- Start
- Aug 2026
- Primary completion
- Feb 2029
- Countries
- 1
01
Overview
A Phase 3 trial of felcorekibart in asthma, sponsored by GSK. Started Aug 2026; status: recruiting.
02
Drugs
felcorekibart
03
Conditions
asthma
Beyond the preview
Go deeper on NCT07780643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07780643.